TET2 c.3391_3393delinsAAC ;(p.P1131N)

Variant ID: 4-106158490-CCA-AAC

NM_001127208.2(TET2):c.3391_3393delinsAAC;(p.P1131N)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma.

Hemasphere
Laribi, Kamel K; Baugier de Materre, Alix A; Touileb, Yamina Y; Boursot, Charles C; Sandrini, Jeremy J; Cavalieri, Doriane D; Pastoret, Cédric C; de Leval, Laurence L; Tournilhac, Olivier O
Publication Date: 2022-02

Variant appearance in text: TET2: Pro1131Asn
PubMed Link: 35141469
Variant Present in the following documents:
  • Main text
  • hs9-6-e675.pdf
View BVdb publication page